Sumit Verma

Senior Vice President, Commercial Manufacturing • Iovance Biotherapeutics Inc

Sumit Verma currently serves as Vice President Commercial Manufacturing for Iovance Biotherapeutics – A San Francisco based Immuno-Oncology company dedicated to providing novel products for curing cancer. He has executive responsibilities for building a new pharmaceutical manufacturing facility and commercial manufacturing organization that will be involved in providing life-saving cancer therapies across North America and Europe.

Prior to Iovance, he has had multiple leadership roles at Merck, Covidien, Mallinckrodt and most recently served as the Chief Operating Officer for Curium Pharmaceuticals. He has successfully led his respective teams in four new FDA-approved drug launches over the past 10 years.

Sumit received his Bachelor of Science in Chemical Engineering from Lafayette College and Master’s in Engineering Management from Washington University in St. Louis and is fluent in 4 languages. He is a certified PMP® professional, has a Six Sigma Black belt and holds 13 U.S patents in pharmaceutical technology and drug development.

Also Speaking

Michael Von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen

Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

David Chang

Chief Executive Officer • WuXi Advanced Therapies

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.